PL3937988T3 - Kontrast MRI do zastosowania w diagnostyce wczesnych zmian w śródbłonku naczyń krwionośnych - Google Patents
Kontrast MRI do zastosowania w diagnostyce wczesnych zmian w śródbłonku naczyń krwionośnychInfo
- Publication number
- PL3937988T3 PL3937988T3 PL20727397.0T PL20727397T PL3937988T3 PL 3937988 T3 PL3937988 T3 PL 3937988T3 PL 20727397 T PL20727397 T PL 20727397T PL 3937988 T3 PL3937988 T3 PL 3937988T3
- Authority
- PL
- Poland
- Prior art keywords
- endothelium
- diagnosis
- changes
- blood vessels
- contrast agent
- Prior art date
Links
- 239000002616 MRI contrast agent Substances 0.000 title 1
- 210000004204 blood vessel Anatomy 0.000 title 1
- 238000003745 diagnosis Methods 0.000 title 1
- 210000003038 endothelium Anatomy 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
- A61K49/1806—Suspensions, emulsions, colloids, dispersions
- A61K49/1812—Suspensions, emulsions, colloids, dispersions liposomes, polymersomes, e.g. immunoliposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
- A61K49/085—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier conjugated systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
- A61K49/10—Organic compounds
- A61K49/101—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals
- A61K49/103—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals the complex-forming compound being acyclic, e.g. DTPA
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y30/00—Nanotechnology for materials or surface science, e.g. nanocomposites
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y40/00—Manufacture or treatment of nanostructures
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
Landscapes
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Radiology & Medical Imaging (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Dispersion Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL429231A PL429231A1 (pl) | 2019-03-11 | 2019-03-11 | Kontrast MRI do diagnostyki wczesnych zmian w śródbłonku naczyń krwionośnych |
| PCT/PL2020/050021 WO2020185104A1 (en) | 2019-03-11 | 2020-03-11 | Mri contrast agent for use in the diagnosis of early changes in the endothelium of blood vessels |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3937988T3 true PL3937988T3 (pl) | 2023-10-02 |
Family
ID=70779829
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL429231A PL429231A1 (pl) | 2019-03-11 | 2019-03-11 | Kontrast MRI do diagnostyki wczesnych zmian w śródbłonku naczyń krwionośnych |
| PL20727397.0T PL3937988T3 (pl) | 2019-03-11 | 2020-03-11 | Kontrast MRI do zastosowania w diagnostyce wczesnych zmian w śródbłonku naczyń krwionośnych |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL429231A PL429231A1 (pl) | 2019-03-11 | 2019-03-11 | Kontrast MRI do diagnostyki wczesnych zmian w śródbłonku naczyń krwionośnych |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20220143224A1 (pl) |
| EP (1) | EP3937988B1 (pl) |
| ES (1) | ES2949943T3 (pl) |
| PL (2) | PL429231A1 (pl) |
| WO (1) | WO2020185104A1 (pl) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050112065A1 (en) * | 2003-07-09 | 2005-05-26 | Drummond Daryl C. | Remote detection of substance delivery to cells |
| US8192721B2 (en) * | 2007-12-13 | 2012-06-05 | Verrow Pharmaceuticals, Inc. | Compositions useful for reducing toxicity associated with gadolinium-based contrast agents |
-
2019
- 2019-03-11 PL PL429231A patent/PL429231A1/pl unknown
-
2020
- 2020-03-11 ES ES20727397T patent/ES2949943T3/es active Active
- 2020-03-11 WO PCT/PL2020/050021 patent/WO2020185104A1/en not_active Ceased
- 2020-03-11 PL PL20727397.0T patent/PL3937988T3/pl unknown
- 2020-03-11 US US17/433,657 patent/US20220143224A1/en active Pending
- 2020-03-11 EP EP20727397.0A patent/EP3937988B1/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP3937988A1 (en) | 2022-01-19 |
| EP3937988B1 (en) | 2023-04-12 |
| ES2949943T3 (es) | 2023-10-04 |
| PL429231A1 (pl) | 2020-09-21 |
| US20220143224A1 (en) | 2022-05-12 |
| WO2020185104A1 (en) | 2020-09-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TR201905882T4 (tr) | Dağıtım aparatı. | |
| EP3203923A4 (en) | Organizer for surgical instruments and items used during surgery | |
| JP2015531397A5 (pl) | ||
| WO2014017853A3 (ko) | Tof-mra를 이용한 혈류특성 및 mr-신호강도구배(전단율) 유도방법 | |
| PL2997992T3 (pl) | Mechanizm do prowadzenia i/lub zwalniania endoprotezy przy uszkodzonych obszarach naczynia krwionośnego, stosowany w cewnikopodobnym urządzeniu medycznym | |
| NZ710436A (en) | Biospecific agents for bone | |
| SG11201405136PA (en) | Intravascular line and port cleaning methods, methods of administering an agent intravascularly, methods of obtaining/testing blood, and devices for performing such methods | |
| EP4356967A3 (en) | Compounds for use as imaging agents | |
| IL278240A (en) | J and their medical/diagnostic uses | |
| PL3937988T3 (pl) | Kontrast MRI do zastosowania w diagnostyce wczesnych zmian w śródbłonku naczyń krwionośnych | |
| HUE071733T2 (hu) | Folyamatos vércukorszintmérésre szolgáló testre rögzíthetõ egység | |
| GB201508958D0 (en) | Process for the preparation of a topography for improved blood coagulation and/or cell attachment on a body made of titanium or a titanium alloy | |
| PT3685144T (pt) | Imagiologia de tecidos biológicos e outros alvos | |
| EP3470091A4 (en) | NONINVASIVE DIAGNOSTIC CONTRASTANT FOR HEART DISEASES | |
| IL286029A (en) | Potassium binding agents for use in hemodialysis patients | |
| EP3378947A4 (en) | Use of ed-b protein in diagnosis of tissue hyperplasia | |
| SG11201707788UA (en) | System and hand-held probe for non-invasive real time magnetic resonance analysis of body tissue | |
| GB2587656B (en) | Non-Invasive system for testing blood glucose and method of the same | |
| EP3695230A4 (en) | SELECTION BIOMARKERS FOR PATIENT STRATIFICATION IN BODY FLUIDS AND THE APPLICATION OF PRECISION MEDICINE BY NEW DIAGNOSTIC BIOMARKERS | |
| CA213620S (en) | Ultrasound probe for medical use | |
| ZA202107125B (en) | System for non-invasive examination of blood environment parameters | |
| UA88362U (ru) | Способ ультразвуковой навигации феморального артериального сосудистого доступа в эндоваскулярной хирургии | |
| CA190051S (en) | Instrument for medical diagnosis | |
| GB201909873D0 (en) | Single use tourniquet for medical purposes | |
| IL284887A (en) | Microcatheter for therapeutic and/or diagnostic interventions in the subarachnoid space |